Thrombophilia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombophilia}} | {{Thrombophilia}} | ||
{{CMG}} {{asiri}} | {{CMG}} {{AE}} {{asiri}} | ||
==Overview== | ==Overview== | ||
Refer to [[Thrombophilia_medical_therapy|medical therapy for thrombophilias]]. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Refer to [[Thrombophilia_medical_therapy|medical therapy for thrombophilias]]. | Refer to [[Thrombophilia_medical_therapy|medical therapy for thrombophilias]]. | ||
Revision as of 05:14, 16 July 2016
|
Thrombophilia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombophilia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Thrombophilia secondary prevention |
|
Risk calculators and risk factors for Thrombophilia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]
Overview
Refer to medical therapy for thrombophilias.
Secondary Prevention
Refer to medical therapy for thrombophilias.